In summary, besides BCR-ABL-dependent mechanisms, other mechanisms are implicated in the DNA methylation alterations observed in the CML clone and they might be involved in the observed intra-clonal epigenetic heterogeneity (Table 2), and in the mechanisms of resistance of immature cells to targeted therapy. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.